Pranay Godha
#207Managing Director and CEO
53
Age
22y
Exp
22y
Tenure
5/10
Risk
🎓 B.Sc · University of Bombay
📜 MBA · New York Institute of Technology, USA
🏛️ None
CompensationTBP
Personality
5
Open
6
Cons
4
Extr
5
Agre
4
Neur
Ipca Labs.
Healthcare · Large Cap
Mature Stable · Hierarchical
About
Pranay Godha is the Managing Director and CEO of Ipca Labs., a Large Cap company in the Healthcare sector with a market cap of ₹38K Cr. A Pragmatic leader with 22 years of experience, he is known for authority-driven decision-making and organic builder strategy. Maintains a steady-handed approach to domestic and export market growth, focusing on vertical integration and core pharmaceutical manufacturing strengths.
FAQ
What is Pranay Godha's leadership style?
Pranay Godha is classified as a Pragmatic leader. He is authority-driven in decision-making, with a dynasty builder motivation and steady-marathon pace of execution.
What is Pranay Godha's educational background?
Pranay Godha holds a B.Sc from University of Bombay and a MBA from New York Institute of Technology, USA.
Who is the CEO of Ipca Labs.?
Pranay Godha is the Managing Director and CEO of Ipca Labs.. He has been with the company for 22 years and in the current role for 2 years.
Leadership DNA
ArchetypePragmatic
MotivationDynasty Builder
CrisisSteady Hand
DecisionAuthority-Driven
GrowthOrganic Builder
PeopleRelationship Led
InnovationFast-Follower
PaceSteady-Marathon
PurposeProfit-Pure
CustomerB2B-Enterprise
EmployerSteady Employer
BrandTechnical-Expert
FocusMarket Expansion
OrientationDeep Specialist
Leadership Evidence
“Maintains a steady-handed approach to domestic and export market growth, focusing on vertical integration and core pharmaceutical manufacturing strengths.”
⚡ Crisis●●●●○
Ipca Labs maintained operational stability and consistent R&D investment throughout the USFDA regulatory challenges between 2015-2020 rather than radical restructuring.
🎯 Motivation●●●●●
Pranay Godha is the son of founder Premchand Godha and has been systematically groomed and positioned to lead the multi-generational family-controlled enterprise.
👥 People●●●○○
The company maintains a culture of long-tenured leadership and stability characteristic of family-managed pharmaceutical firms in India.
📈 Growth●●●●○
Ipca's growth has been primarily driven by capacity expansion at its manufacturing plants and deepening its portfolio in APIs and formulations.
💡 Innovation●●●●○
Ipca focuses on high-quality generic manufacturing and vertical integration in APIs rather than pioneering novel drug discovery.
🏃 Pace●●●●○
The company has maintained a consistent, long-term growth trajectory in domestic formulations and international API exports over several decades.
🌱 Purpose●●●○○
The company maintains a traditional corporate structure focused on operational efficiency and margins in the competitive generic pharmaceutical landscape.
🏷️ Brand●●●●○
Ipca is widely recognized in the industry for its deep technical expertise in complex API chemistry, particularly in therapeutic areas like anti-malarials.
🤝 Customer●●●●○
A significant portion of revenue is derived from supplying APIs to global pharmaceutical companies and institutional sales to government health programs.
💼 Employer●●●○○
Known for a stable, process-oriented work environment typical of mature, promoter-led Indian pharmaceutical manufacturing firms.
📋 Mandate
To sustain growth in international markets, the company needs a leader focused on navigating complex global regulatory frameworks and compliance standards.
🏢 Culture●●●○○
Stable, long-established pharmaceutical entity with a traditional corporate hierarchy and focus on steady execution.
Financials
Revenue FY25₹9K Cr
PAT FY25₹738 Cr
Rev CAGR 5Y15.4%
OPM15.3%
NPM8.3%
ROE10.6%
ROCE14.5%
P/E43.5
Fwd P/E28.9
P/B4.8
D/E14.4
Promoter45.1%
Institutional46.6%
Mkt Cap₹38K Cr
Compensation
To Be Published
Data being verified from audited reports
